Skip to main content
. 2020 Nov 4;12(11):3251. doi: 10.3390/cancers12113251

Table 2.

Comparison of overall AE burden score (TB) between active treatment and placebo.

NCCTG 97-24-51
TB CAI
(N = 85)
Placebo
(N = 91)
p-Value
(Wilcoxon)
Mean (SD) 6.1 (4.4) 3.9 (5.0)
Median (range) 5.0 (0.0–24.0) 2.8 (0.0–37.0) <0.0001
A091105
TB Sorafenib
(N = 49)
Placebo
(N = 36)
p-Value
(Wilcoxon)
Mean (SD) 4.4 (3.2) 3.1 (3.0)
Median (range) 3.6 (0.7–18.5) 2.0 (0.0–13.5) 0.0042